An estrogen receptor mutant with strong hormone-independent activity from a metastatic breast cancer

Cancer Research

Volumn 57, Issue 7, 1997, Pages 1244-1249

  Zhang, Qiu Xia ^a   Borg, Åke ^a   Wolf, Douglas M ^b   Oesterreich, Steffi ^b   Fuqua, Suzanne A W ^b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; ESTROGEN RECEPTOR; N BUTYL 11 (3,17BETA DIHYDROXYESTRA 1,3,5(10) TRIEN 7ALPHA YL) N METHYLUNDECANAMIDE; TAMOXIFEN;

ARTICLE; BREAST CANCER; CONFORMATIONAL TRANSITION; DIMERIZATION; DNA SEQUENCE; HORMONE BINDING; HORMONE RELEASE; HUMAN; HUMAN TISSUE; MISSENSE MUTATION; PRIORITY JOURNAL; REPORTER GENE; SINGLE STRAND CONFORMATION POLYMORPHISM; TRANSACTIVATION; TRANSCRIPTION REGULATION;

BREAST NEOPLASMS; ESTRADIOL; FEMALE; HELA CELLS; HUMANS; MODELS, GENETIC; MUTATION; NEOPLASM METASTASIS; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RECEPTORS, ESTROGEN; TAMOXIFEN; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 0030940071     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Evans, R. M. The steroid and thyroid hormone receptor superfamily, Science (Washington DC), 240: 889-895, 1988.
2. Kumar, V., Green, S., Stack, G., Berry, M., Jin, J. R., and Chambon, P. Functional domains of the human estrogen receptor. Cell, 51: 941-951, 1987.
3. Berry, M., Metzger, D., and Chambon, P. Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen. EMBO J., 9: 2811-2818, 1990.
4. Halachmi, S., Marden, E., Martin, G., MacKay, H., Abbondanza, C., and Brown, M. Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription. Science (Washington DC), 264: 1455-1458, 1994.
5. Kato, S., Endoh, H., Masuhiro, Y., Kitamoto, Y., Uchiyama, S., Sasaki, H., Masushige, S., Gotoh, Y., Nishida, E., Kawashima, H., Metzger, D., and Chambon, P. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science (Washington DC), 270: 1491-1494, 1995.
6. Arnold, S. F., Obourn, J. D., Jaffe, H., and Notides, A. C. Phosphorylation of the human estrogen receptor on tyrosine 537 in vivo and by Src family tyrosine kinases in vitro, Mol. Endocrinol., 9: 24-33, 1995.
7. Clark, G. M., and McGuire, W. L. Steroid receptors and other prognostic factors in primary breast cancer. Semin. Oncol., 15: 20-25, 1988.
8. Fuqua, S. A. W., Chamness, G. C., and McGuire, W. L. Estrogen receptor mutations in breast cancer J. Cell. Biochern., 51: 135-139, 1993.
9. Fuqua, S. A. W., Fitzgerald, S. D., Allred, D. C., Elledge, R. M., Nawaz, Z., McDonnell, D. P., O'Malley, B. W., Greene, G. L., and McGuire, W. L. Inhibition of estrogen receptor action by a naturally occurring variant in human breast tumors. Cancer Res., 52: 483-486, 1992.
10. Fuqua, S. A. W., Fitzgerald, S. D., Chamness, G. C., Tandon, A. K., McDonnell, D. P., Nawaz, Z., O'Malley, B. W., and McGuire, W. L. Variant human breast tumor estrogen receptor with constitutive transcriptional activity. Cancer Res., 57: 105-109, 1991.
11. Zhang, Q-X, Borg, Å., and Fuqua, S. A. W. An exon 5 deletion variant of the estrogen receptor frequently coexpressed with wild-type estrogen receptor in breast cancer. Cancer Res., 53: 5882-5884, 1993.
12. Zhang, Q-X., Hilsenbeck, S., Fuqua, S. A. W., and Borg, Å. Multiple splicing variants of the estrogen receptor are present in individual breast tumors. J. Steroid Biochem. Mol. Biol., 59: 251-260, 1996.
13. Garcia, T., Sanchez, M., Cox, J. L., Shaw, P. A., Ross, J. B. A,. Lehrer, S., and Schachter, B. Identification of a variant from of the human estrogen receptor with an amino acid replacement. Nucleic Acids Res., 17: 8364, 1989.
14. Karnik, P. S., Kullkarni, S., Liu, X-P., Budd, G. T., and Bukowski, R. M. Estrogen receptor mutations in tamoxifen-resistant breast cancer. Cancer Res., 54: 349-353, 1994.
15. Roodi, N., Bailey, L. R., Kao, W-Y., Verrier, C. S., Yee, C. J., Dupont, W. D., and Parl, F. F. Estrogen receptor gene analysis in estrogen receptor-positive and receptor-negative primary breast cancer J. Natl. Cancer Inst., 87: 446-451, 1995.
16. l6. Sambrook, J., Fritsch, E. F., and Maniatis, T. Molecular Cloning: A Laboratory Manual, Ed. 2, pp. 9.16-9.23. New York: Cold Spring Harbor Laboratory Press, 1989.
17. Ponglikitmongkol, M., Green, S., and Chambon, P. Genomic organization of the human oestrogen receptor gene. EMBO J., 7: 3385-3388, 1988.
18. Orita, M., Iwahara, H., Kanazawa, H., Hayashis, K., and Sekiya, T. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformational polymorphous. Proc. Natl. Acad. Sci. USA, 86: 2766-2770, 1989.
19. Sanger, F., Nicklen, S., and Coulson, A. R. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA, 74: 5463-5467, 1977.
20. Greene, G. L., Gilna, P., Waterfield, M., Baker, A., Hort, Y., and Shine, J. Sequence and expression of human estrogen receptor complementary DNA. Science (Washington DC), 231: 1150-1154, 1986.
21. Kraus, W. L., Montano, M. M., and Katzenellenbogen, B. S. Cloning of the rat progesterone receptor gene 5′-region and identification of two functionally distinct promoters. Mol. Endocrinol., 7: 1603-1616, 1993.
22. Teng, C. T., Liu, Y., Yang, N., Walmer, D., and Panella, T. Differential molecular mechanisms of the estrogen action that regulates lactoferrin gene in human and mouse. Mol. Endocrinol., 6: 1969-1981, 1992.
23. Nunez, A-M., Berry, M., Imler, J-L., and Chambon, P. The 5′ flanking region of the pS2 gene contains a complex enhancer region responsive to oestrogens, epidermal growth factor, a tumour promoter (TPA), the c-Ha-ras oncoprotein and the c-jun protein. EMBO J., 8: 823-829, 1989.
24. Augereau, P., Miralles, F., Cavailles, V., Gaudelet, C., Parker, M., and Rochefort, H. Characterization of the proximal estrogen-responsive element of human cathepsin D gene. Mol. Endocrinol., 8: 693-703, 1994.
25. Tzukerman, M. T., Esty, A., Santiso-Mere, D., Danielian, P., Parker, M. G., Stein, R. B., Pike, J. W., and McDonnell, D. P. Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Mol. Endocrinol., 8: 21-30, 1994.
26. Lees, J. A., Fawell, S. E., and Parker, M. G. Identification of two transactivation domains in the mouse oestrogen receptor. Nucleic Acids Res., 17: 5477-5488, 1989.
27. Fawell, S. E., Lees, J. A., and Parker, M. G. A proposed consensus steroid-binding sequence: a reply. Mol. Endocrinol., 3: 1002-1005, 1989.
28. Kraus, W. L., McInerney, E. M., and Katzenellenbogen, B. S. Ligand-dependent, transcriptionally productive association of the amino- and carboxyl-terminal regions of a steroid hormone nuclear receptor. Proc. Natl. Acad. Sci. USA, 92: 12314-12318, 1995.
29. Arnold, S. F., Obourn, J. D., Jaffe, H., and Notides, A. C. Phosphorylation of the human estrogen receptor on tyrosine 537 in vivo and by src family tyrosine kinases in vitro. Mol. Endocrinol., 9: 24-33, 1995.
30. Castoria, G., Migliaccio, A., Green, S., Di Domenico, M., Chambon, P., and Auricchio, F. Properties of a purified estradiol-dependent calf uterus tyrosine kinase. Biochemistry, 32: 1740-1750, 1993.
31. Arnold, S. F., and Notides, A. C. An antiestrogen: a phospholyrosyl peptide that blocks dimerization of the human estrogen receptor Proc. Natl. Acad. Sci. USA, 92: 7475-7479, 1995.
32. Fawell, S. E., Lees, J. A., White, R., and Parker, M. G. Characterization and colocalization of steroid binding and dimerization activities in the mouse estrogen receptor. Cell, 60: 953-962, 1990.
33. Le Goff, P., Montano, M. M., Schodin, D. J., and Katzenellenbogen, B. S. Phorphorylation of the human estrogen receptor: identification of hormone-regulated sites and examination of their influence on transcriptional activity. J. Biol. Chem., 269: 4458-4466, 1994.
34. Pietras, R. J., Arboleda, J., Reese, D. M., Wongvipat, N., Pegram, M. D., Ramos, L., Gorman, C. M., Parker, M. G., Sliwkowski, M. X., and Slamon, D. J. HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells. Oncogene, 10: 2435-2446, 1995.